Literature DB >> 365431

Implications of prostacyclin generation for modulation of vascular tone.

G J Dusting, S Moncada, K M Mullane, J R Vane.   

Abstract

1. The biotransformation of arachidonic acid and prostacyclin in the circulation was studied in anaesthetized dogs, using the blood-bathed organ technique. 2. In passage through the lungs, arachidonate (50-800 microgram kg-1 min-1) was transformed into prostacyclin. No thromboxane A2 or prostaglandin E2 could be detected in arterial blood. 3. In dogs treated with indomethacin (5 mg/kg), intravenous infusions of arachidonate had no cardiovascular effects and no prostacyclin was produced. Therefore, the vasodilator effects of arachidonate in vivo may be attributable to prostacyclin formation. 4. Prostacyclin, unlike prostaglandin E2, is not inactivated by passage across the lungs, and only about 50% disappears in one passage through peripheral vascular beds. 5. Thus prostacyclin released from the lungs could function as a circulating vasodilator and contribute to the regulation of blood vessel tone and blood pressure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365431     DOI: 10.1042/cs055195s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  5 in total

Review 1.  Endothelial dysfunction: the link between homocysteine and hydrogen sulfide.

Authors:  Sathnur Pushpakumar; Sourav Kundu; Utpal Sen
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

2.  Increased levels of 6-oxo-PGF1 alpha in human skin following ultraviolet B irradiation.

Authors:  A K Black; C N Hensby; M W Greaves
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

3.  Cigarette smoke inhalation specifically inhibits depressor responses to prostacyclin in the rat.

Authors:  A L Boura; S C Hui; W A Walters
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

4.  Mechanisms involved in the vasorelaxant effects produced by the acute application of amfepramone in vitro to rat aortic rings.

Authors:  J S López-Canales; J Lozano-Cuenca; E Muãoz-Islas; J C Aguilar-Carrasco; O A López-Canales; R M López-Mayorga; E F Castillo-Henkel; I Valencia-Hernández; C Castillo-Henkel
Journal:  Braz J Med Biol Res       Date:  2015-03-27       Impact factor: 2.590

5.  Possible mechanisms involved in the vasorelaxant effect produced by clobenzorex in aortic segments of rats.

Authors:  J Lozano-Cuenca; A González-Hernández; O A López-Canales; J R Villagrana-Zesati; J D Rodríguez-Choreão; R Morín-Zaragoza; E F Castillo-Henkel; J S López-Canales
Journal:  Braz J Med Biol Res       Date:  2017-08-07       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.